Archive | CPC Scientific Inc

Page 1 of 1
CPC Scientific Announces U.S. FDA Pre-License Inspection (PLI) Successfully Completed at Its Hangzhou cGMP Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent BLA Pathway
CPC Scientific Announces U.S. FDA Pre-License Inspection (PLI) Successfully Completed at Its Hangzhou cGMP Manufacturing Facility for Hepcludex®… Learn More >
57468CPC Scientific Advances Green Chemistry Approaches for Scalable TIDES Manufacturing
CPC Scientific Advances Green Chemistry Approaches for Scalable TIDES Manufacturing Learn More >
CPC Scientific’s Tirzepatide API Successfully Secures US FDA DMF Filing, Fully Empowering the Global Weight Loss and Metabolism Arena
CPC Scientific’s Tirzepatide API Successfully Secures US FDA DMF Filing, Fully Empowering the Global Weight Loss and Metabolism… Learn More >
Toward Greener Peptide Manufacturing – Advancing DMF Efficiency in SPPS
Toward Greener Peptide Manufacturing – Advancing DMF Efficiency in SPPS Learn More >
Enabling Sustainable Large-Scale SPPS Through Process Innovations
Enabling Sustainable Large-Scale SPPS Through Process Innovations Learn More >
CPC Scientific Showcases Peptide and Oligonucleotide CRDMO Leadership at Major Q1 2026 Pharma Events
CPC Scientific Showcases Peptide and Oligonucleotide CRDMO Leadership at Major Q1 2026 Pharma Events Learn More >
57063Peptides and Oligonucleotides in Precision and Personalized Medicines
Peptides and Oligonucleotides in Precision and Personalized Medicines Learn More >
GMP Manufacturing for Peptide and Oligonucleotide Therapeutics – Ensuring Quality and Scale
GMP Manufacturing for Peptide and Oligonucleotide Therapeutics – Ensuring Quality and Scale Learn More >
CPC Scientific Brings Peptide and Oligonucleotide CRDMO Solutions to TIDES Europe 2025
CPC Scientific Brings Peptide and Oligonucleotide CRDMO Solutions to TIDES Europe 2025 Learn More >
CPC Scientific to Showcase Peptide and Oligonucleotide CDMO Leadership at CPHI Frankfurt 2025
CPC Scientific to Showcase Peptide and Oligonucleotide CDMO Leadership at CPHI Frankfurt 2025 Learn More >
Page 1 of 1